Our laboratory has been investigating the role of neutrophils in tumor angiogenesis and in resistance to anti-angiogenic therapies with VEGF inhibitors and these efforts led to the identification of neutrophil-derived angiogenic factors such as Bv8/PROK2 (100–102). The gene discussed is PROK2; the disease is neoplasm.